New video of investigators introducing COMBI-BIO

Combi-BIO is a EU funded FP7 project led by Professor Paul Elliott at Imperial College London that aims to use top down systems biology approaches based on metabolic phenotyping and computational medicine to discover, test and validate novel biomarkers for subclinical atherosclerosis, and develop prognostic combinational biomarkers and risk scores to improve early prediction and patient stratification/management for subclinical atheroscleriosis.


A new video of investigators involved with COMBI-BIO for more information about the project